EX-99.2 3 ex992to13d10407opt_03022017.htm JOINT FILING AGREEMENT
Exhibit 99.2
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, par value $0.001 per share, of OptimizeRx Corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: March 6, 2017

| WOLVERINE ASSET MANAGEMENT, LLC
| By: | /s/ Niraj M. Patel
|  | Name: | Niraj M. Patel
|  | Title: | Chief Legal Officer

| WOLVERINE HOLDINGS, L.P.
| By: | /s/ Christopher L. Gust
|  | Name: | Christopher L. Gust
|  | Title: | Managing Director

| WOLVERINE TRADING PARTNERS, INC.
| By: | /s/ Christopher L. Gust
|  | Name: | Christopher L. Gust
|  | Title: | Authorized signatory

| By: | /s/ Christopher L. Gust
|  | Name: | Christopher L. Gust

| By: | /s/ Robert R. Bellick
|  | Name: | Robert R. Bellick